Nasopharyngeal Diseases  >>  erlotinib  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
erlotinib / Generic mfg.
NCT00603915: A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

Completed
2
20
Canada
Gemcitabine, Carboplatin/Cisplatin, erlotinib
University Health Network, Toronto, Hoffmann-La Roche
Nasopharyngeal Cancer
12/10
04/11

Download Options